0 XP   0   0   0

OKYO Pharma Ltd ADR
Buy, Hold or Sell?

I guess you are interested in OKYO Pharma Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse OKYO Pharma Ltd ADR

Let's start. I'm going to help you getting a better view of OKYO Pharma Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is OKYO Pharma Ltd ADR even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how OKYO Pharma Ltd ADR is doing in the market. If the company is worth buying. The latest step is to find out how other investors value OKYO Pharma Ltd ADR. The closing price on 2022-10-03 was $2.7 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
OKYO Pharma Ltd ADR Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of OKYO Pharma Ltd ADR.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit OKYO Pharma Ltd ADR earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--256.4%+256.4%
TTM--281.5%+281.5%
YOY--344.8%+344.8%
5Y--492.0%+492.0%
10Y--561.7%+561.7%
1.1.2. Return on Assets

Shows how efficient OKYO Pharma Ltd ADR is using its assets to generate profit.

  • Above 5% is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • 0.0% Return on Assets means that OKYO Pharma Ltd ADR generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--9.9%+9.9%
TTM--8.7%+8.7%
YOY--9.3%+9.3%
5Y--11.6%+11.6%
10Y--12.3%+12.3%
1.1.3. Return on Equity

Shows how efficient OKYO Pharma Ltd ADR is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • 0.0% Return on Equity means the company generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--12.0%+12.0%
TTM--10.9%+10.9%
YOY--10.7%+10.7%
5Y--13.8%+13.8%
10Y--14.7%+14.7%

1.2. Operating Efficiency of OKYO Pharma Ltd ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient OKYO Pharma Ltd ADR is operating .

  • Measures how much profit OKYO Pharma Ltd ADR makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare OKYO Pharma Ltd ADR to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM--266.2%+266.2%
YOY--311.8%+311.8%
5Y--472.5%+472.5%
10Y--560.3%+560.3%
1.2.2. Operating Ratio

Measures how efficient OKYO Pharma Ltd ADR is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.270-3.270
TTM-3.490-3.490
YOY-3.442-3.442
5Y-5.620-5.620
10Y-6.585-6.585

1.3. Liquidity of OKYO Pharma Ltd ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if OKYO Pharma Ltd ADR is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.17 means the company has $3.17 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 3.174. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.060. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.174TTM6.060-2.886
TTM6.060YOY4.092+1.968
TTM6.0605Y5.667+0.394
5Y5.66710Y5.6670.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1745.117-1.943
TTM6.0605.755+0.305
YOY4.0925.878-1.786
5Y5.6676.514-0.847
10Y5.6676.212-0.545
1.3.2. Quick Ratio

Measures if OKYO Pharma Ltd ADR is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 2.65 means the company can pay off $2.65 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 2.649. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.174. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.649TTM3.174-0.526
TTM3.174YOY4.080-0.906
TTM3.1745Y3.355-0.181
5Y3.35510Y3.3550.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6493.813-1.164
TTM3.1744.348-1.174
YOY4.0804.712-0.632
5Y3.3554.779-1.424
10Y3.3554.467-1.112

1.4. Solvency of OKYO Pharma Ltd ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of OKYO Pharma Ltd ADR assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.31 means that OKYO Pharma Ltd ADR assets are financed with 31.5% credit (debt) and the remaining percentage (100% - 31.5%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.315. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.200. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.315TTM0.200+0.114
TTM0.200YOY0.250-0.050
TTM0.2005Y0.210-0.010
5Y0.21010Y0.2100.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3150.274+0.041
TTM0.2000.274-0.074
YOY0.2500.304-0.054
5Y0.2100.366-0.156
10Y0.2100.400-0.190
1.4.2. Debt to Equity Ratio

Measures if OKYO Pharma Ltd ADR is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 45.9% means that company has $0.46 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of OKYO Pharma Ltd ADR:

  • The MRQ is 0.459. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.265. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.459TTM0.265+0.194
TTM0.265YOY0.333-0.068
TTM0.2655Y0.279-0.014
5Y0.27910Y0.2790.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4590.311+0.148
TTM0.2650.315-0.050
YOY0.3330.321+0.012
5Y0.2790.398-0.119
10Y0.2790.454-0.175

2. Market Valuation of OKYO Pharma Ltd ADR

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in OKYO Pharma Ltd ADR.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 0.00 means the investor is paying $0.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of OKYO Pharma Ltd ADR:

  • The EOD is -529.623. Company is losing money. -2
  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
EOD-529.623MRQ--529.623
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-529.623-2.215-527.408
MRQ--2.524+2.524
TTM--4.050+4.050
YOY--5.007+5.007
5Y--3.850+3.850
10Y--3.475+3.475

2. Books
2.3. Price to Book Ratio

Measures if the stock price of OKYO Pharma Ltd ADR is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.00 means the investor is paying $0.00 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of OKYO Pharma Ltd ADR:

  • The EOD is 1,259.039. Seems overpriced? -1
  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
EOD1,259.039MRQ-+1,259.039
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1,259.0391.932+1,257.107
MRQ-2.138-2.138
TTM-2.946-2.946
YOY-3.587-3.587
5Y-2.909-2.909
10Y-2.520-2.520

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of OKYO Pharma Ltd ADR.

3.1. Institutions holding OKYO Pharma Ltd ADR

Institutions are holding 0.141% of the shares of OKYO Pharma Ltd ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Citadel Advisors Llc0.127026864268640
2022-06-30UBS Group AG0.01730366736670
2022-06-30Tower Research Capital LLC0.001102292290
Total 0.1454030760  

4. Summary

4.1. Key Performance Indicators

The key performance indicators of OKYO Pharma Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.0020.005-54%0.006-63%0.005-56%0.005-56%
Book Value Per Share Growth---0.003-0.001-73%0.006-158%0.000-876%0.000-876%
Current Ratio--3.1746.060-48%4.092-22%5.667-44%5.667-44%
Debt To Asset Ratio--0.3150.200+57%0.250+26%0.210+50%0.210+50%
Debt To Equity Ratio--0.4590.265+73%0.333+38%0.279+65%0.279+65%
Dividend Per Share----0%-0%-0%-0%
Eps---0.001-0.001+64%-0.002+98%-0.001+71%-0.001+71%
Gains Per Share---0.003-0.001-73%0.006-158%0.000-876%0.000-876%
Gross Profit Margin----0%-0%-0%-0%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio1259.039+100%--0%-0%-0%-0%
Pe Ratio-529.6230%--0%-0%-0%-0%
Price Per Share2.700+100%--0%-0%-0%-0%
Quick Ratio--2.6493.174-17%4.080-35%3.355-21%3.355-21%
Return On Assets----0%-0%-0%-0%
Return On Equity----0%-0%-0%-0%
 EOD+0 -2MRQTTM+1 -7YOY+1 -75Y+1 -710Y+1 -7

4.2. Fundamental Score

Let's check the fundamental score of OKYO Pharma Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-529.623
Price to Book Ratio (EOD)Between0-11,259.039
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.649
Current Ratio (MRQ)Greater than13.174
Debt to Asset Ratio (MRQ)Less than10.315
Debt to Equity Ratio (MRQ)Less than10.459
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of OKYO Pharma Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.246
Ma 20Greater thanMa 502.940
Ma 50Greater thanMa 1002.494
OpenGreater thanClose2.700
Total1/4 (25.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets4,301
Total Liabilities1,353
Total Stockholder Equity2,947
 As reported
Total Liabilities 1,353
Total Stockholder Equity+ 2,947
Total Assets = 4,301

Assets

Total Assets4,301
Total Current Assets4,295
Long-term Assets4,295
Total Current Assets
Cash And Cash Equivalents 2,701
Net Receivables 883
Other Current Assets 711
Total Current Assets  (as reported)4,295
Total Current Assets  (calculated)4,295
+/-0
Long-term Assets
Property Plant Equipment 5
Long-term Assets  (as reported)5
Long-term Assets  (calculated)5
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,353
Long-term Liabilities0
Total Stockholder Equity2,947
Total Current Liabilities
Accounts payable 742
Other Current Liabilities 611
Total Current Liabilities  (as reported)1,353
Total Current Liabilities  (calculated)1,353
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock123,977
Retained Earnings -112,426
Accumulated Other Comprehensive Income -11,012
Other Stockholders Equity 2,408
Total Stockholder Equity (as reported)2,947
Total Stockholder Equity (calculated)2,947
+/-0
Other
Capital Stock123,977
Cash and Short Term Investments 2,701
Common Stock Shares Outstanding 1,374,405
Liabilities and Stockholders Equity 4,301
Net Debt -2,701
Net Invested Capital 2,947
Net Tangible Assets 2,243
Net Working Capital 2,942



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-03-312019-09-302019-03-312018-09-302018-03-312017-09-302017-03-312016-09-302016-03-312015-09-302015-03-312014-09-302014-03-312013-09-302013-03-312012-09-302012-03-312011-03-312010-09-302010-03-31
> Total Assets 
35,920
10,001
10,013
26,357
30,594
29,748
23,428
28,363
27,759
22,992
22,669
22,395
22,388
22,246
2,876
2,008
1,260
583
502
483
5,840
0
5,138
0
4,177
0
4,301
4,30104,17705,13805,8404835025831,2602,0082,87622,24622,38822,39522,66922,99227,75928,36323,42829,74830,59426,35710,01310,00135,920
   > Total Current Assets 
35,920
10,001
10,013
10,912
13,190
9,593
3,691
7,321
5,585
4,586
4,155
3,737
3,628
3,288
2,834
2,008
1,260
582
501
458
5,817
5,062
5,062
4,113
4,113
3,269
4,295
4,2953,2694,1134,1135,0625,0625,8174585015821,2602,0082,8343,2883,6283,7374,1554,5865,5857,3213,6919,59313,19010,91210,01310,00135,920
       Cash And Cash Equivalents 
17,677
9,990
10,001
10,640
12,938
9,437
3,511
7,104
5,348
4,366
3,942
3,569
3,443
3,146
2,667
2,008
1,244
481
55
190
5,762
0
4,992
0
3,850
0
2,701
2,70103,85004,99205,762190554811,2442,0082,6673,1463,4433,5693,9424,3665,3487,1043,5119,43712,93810,64010,0019,99017,677
       Short-term Investments 
18,238
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000018,238
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55
55
235
235
672
883
8836722352355555000000000000000000000
       Other Current Assets 
5
11
12
272
251
155
180
217
238
221
214
169
185
142
167
0
16
101
446
268
55
0
71
3
263
0
711
711026337105526844610116016714218516921422123821718015525127212115
   > Long-term Assets 
0
0
0
15,445
17,405
20,155
19,737
21,042
22,174
18,406
18,514
18,658
18,760
18,959
43
0
0
1
1
25
24
0
76
0
64
0
5
50640760242511004318,95918,76018,65818,51418,40622,17421,04219,73720,15517,40515,445000
       Property Plant Equipment 
0
0
0
307
16,546
12,257
10,437
11,742
334
223
11,800
11,944
84
12,245
43
0
0
1
1
25
24
76
76
64
64
4
5
5464647676242511004312,2458411,94411,80022333411,74210,43712,25716,546307000
       Goodwill 
0
0
0
0
0
858
644
644
644
429
429
429
429
429
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000042942942942942964464464485800000
       Intangible Assets 
0
0
0
15,138
0
0
8,656
8,656
21,196
6,285
6,285
6,285
18,247
6,285
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000006,28518,2476,2856,2856,28521,1968,6568,6560015,138000
> Total Liabilities 
53
25
49
520
300
121
47
149
197
102
146
126
171
207
236
91
167
327
661
596
343
0
1,284
0
495
0
1,353
1,353049501,28403435966613271679123620717112614610219714947121300520492553
   > Total Current Liabilities 
53
25
49
520
300
121
47
149
197
102
146
126
171
207
236
91
167
327
661
575
324
1,237
1,237
460
460
1,030
1,353
1,3531,0304604601,2371,2373245756613271679123620717112614610219714947121300520492553
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
0
25
0
26
0
0
00260250440000000000000000000
       Accounts payable 
53
0
26
308
53
48
32
74
177
81
143
86
148
147
218
0
90
293
634
480
258
153
153
161
161
565
742
74256516116115315325848063429390021814714886143811777432485330826053
       Other Current Liabilities 
0
25
23
212
247
72
15
75
20
21
3
40
23
60
18
91
78
34
27
90
62
0
1,059
0
274
0
611
611027401,0590629027347891186023403212075157224721223250
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
19
0
47
0
35
0
0
0035047019210000000000000000000
> Total Stockholder Equity
35,867
9,976
9,964
25,822
30,294
29,628
23,381
28,214
27,562
22,890
22,523
22,269
22,217
22,039
2,641
1,917
1,092
255
-159
-113
5,498
0
3,854
0
3,682
0
2,947
2,94703,68203,85405,498-113-1592551,0921,9172,64122,03922,21722,26922,52322,89027,56228,21423,38129,62830,29425,8229,9649,97635,867
   Common Stock
0
0
0
0
0
0
59,819
65,954
0
0
66,192
66,192
0
66,192
66,192
66,368
66,368
68,403
68,803
67,519
67,137
0
0
0
76,371
0
123,977
123,977076,37100067,13767,51968,80368,40366,36866,36866,19266,192066,19266,1920065,95459,819000000
   Retained Earnings 
19,219
-5,829
-5,938
-18,518
-30,186
-31,696
-38,055
-39,654
-39,612
-44,516
-44,868
-45,030
-45,129
-44,354
-63,541
-64,451
-65,644
-68,211
-69,096
-69,424
-70,395
-72,584
-72,584
-74,453
-74,453
-76,849
-112,426
-112,426-76,849-74,453-74,453-72,584-72,584-70,395-69,424-69,096-68,211-65,644-64,451-63,541-44,354-45,129-45,030-44,868-44,516-39,612-39,654-38,055-31,696-30,186-18,518-5,938-5,82919,219
   Capital Surplus 000000000000000000000000000
   Treasury Stock000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
1,617
1,914
0
0
1,198
1,106
0
201
-10
0
369
63
134
1,793
8,756
9,290
9,290
1,764
1,764
1,909
2,408
2,4081,9091,7641,7649,2909,2908,7561,793134633690-1020101,1061,198001,9141,617000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-6,218
Operating Income-6,218-6,218
 
Operating Expense (+$)
Research Development1,301
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense6,2181,301
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Net Interest Income00
 
Pretax Income (+$)
Operating Income-6,218
Net Interest Income0
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-6,218-6,218
EBIT - interestExpense = -6,218
-6,218
-5,431
Interest Expense0
Earnings Before Interest and Taxes (ebit)-6,218-6,218
Earnings Before Interest and Taxes (ebitda)-6,215
 
After tax Income (+$)
Income Before Tax-6,218
Tax Provision--787
Net Income From Continuing Ops-5,431-5,431
Net Income-5,431
Net Income Applicable To Common Shares-3,976
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses6,218
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
PHP.FOREX
34 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PHP.FOREX.

PHP.FOREX Daily Candlestick Chart
KRWMYR.FOREX
36 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of KRWMYR.FOREX.

KRWMYR.FOREX Daily Candlestick Chart
USDPHP.FOREX
43 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of USDPHP.FOREX.

USDPHP.FOREX Daily Candlestick Chart
00642U.TW
57 minutes ago

I found you a Death Cross on the daily chart of 00642U.TW.

00642U.TW Daily Candlestick Chart
00715L.TW
1 hour ago

I found you a Death Cross on the daily chart of 00715L.TW.

00715L.TW Daily Candlestick Chart
2891B.TW
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 2891B.TW.

2891B.TW Daily Candlestick Chart
SRT.HA
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of SRT.HA.

SRT.HA Daily Candlestick Chart
SRT.HM
1 hour ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of SRT.HM.

SRT.HM Daily Candlestick Chart
PMAG.VI
1 hour ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PMAG.VI.

PMAG.VI Daily Candlestick Chart
GR3M.GBOND
2 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of GR3M.GBOND.

GR3M.GBOND Daily Candlestick Chart
IT3Y.GBOND
2 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of IT3Y.GBOND.

IT3Y.GBOND Daily Candlestick Chart
USDMOP.FOREX
3 hours ago

I found you a Golden Cross on the daily chart of USDMOP.FOREX.

USDMOP.FOREX Daily Candlestick Chart
CCAJ.OTCCE
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CCAJ.OTCCE.

CCAJ.OTCCE Daily Candlestick Chart
CAPX.BA
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CAPX.BA.

CAPX.BA Daily Candlestick Chart
BTCS.OTCQB
3 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of BTCS.OTCQB.

BTCS.OTCQB Daily Candlestick Chart
ANAS.PINK
3 hours ago

I found you a RSI Bearish Reversal Divergence on the daily chart of ANAS.PINK.

ANAS.PINK Daily Candlestick Chart
SATOK.AT
3 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SATOK.AT.

SATOK.AT Daily Candlestick Chart
OPAP.AT
3 hours ago

I found you a Death Cross on the daily chart of OPAP.AT.

OPAP.AT Daily Candlestick Chart
MIG.AT
3 hours ago

I found you a Golden Cross on the daily chart of MIG.AT.

MIG.AT Daily Candlestick Chart
ELTON.AT
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ELTON.AT.

ELTON.AT Daily Candlestick Chart
DOMIK.AT
3 hours ago

I found you a Golden Cross on the daily chart of DOMIK.AT.

DOMIK.AT Daily Candlestick Chart
SGDPKR.FOREX
4 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of SGDPKR.FOREX.

SGDPKR.FOREX Daily Candlestick Chart
USDNPR.FOREX
4 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of USDNPR.FOREX.

USDNPR.FOREX Daily Candlestick Chart
EURPHP.FOREX
4 hours ago

I found you a Golden Cross on the daily chart of EURPHP.FOREX.

EURPHP.FOREX Daily Candlestick Chart
JINDCOT.BSE
4 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of JINDCOT.BSE.

JINDCOT.BSE Daily Candlestick Chart